Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RMC-6272 (RM-006) is a bi-steric inhibitor that selectively targets mTORC1, displaying potent and selective (< 10-fold) inhibition over mTORC2. Compared to Rapamycin, RMC-6272 demonstrates enhanced inhibition of mTORC1 and induces increased cell death in TSC2 null tumors.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 1,860.00 | |
10 mg | Inquiry | $ 2,320.00 |
Description | RMC-6272 (RM-006) is a bi-steric inhibitor that selectively targets mTORC1, displaying potent and selective (> 10-fold) inhibition over mTORC2. Compared to Rapamycin, RMC-6272 demonstrates enhanced inhibition of mTORC1 and induces increased cell death in TSC2 null tumors. |
In vitro | RMC-6272 shows more effective growth inhibition in multiple TSC1 or TSC2 mutant tumor cell lines compared to Rapamycin. RMC-6272 causes a more profound growth inhibition in the TSC1 or TSC2 mutant cells than the wild type cells. RMC-6272 at ~1 nM shows near complete inhibition of p4E-BP1 T37/46 , while inhibition of pS6 S240/244 levels is similar for Rapamycin and RM compounds[1]. |
In vivo | RMC-6272 significantly decreases the kidney tumor burden in Tsc2 +/- A/J mice within four weeks of treatment. When assessed two months post-treatment cessation, the tumor burden remains notably lower in the RMC-6272 group compared to both the Rapamycin and MLN0128 groups[1]. |
Synonyms | RM-006, RMC-6272 |
Molecular Weight | 1850.25 |
Formula | C95H141FN6O27S |
CAS No. | 2382769-46-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RMC-6272 2382769-46-0 RM 006 RM-006 RM006 RMC 6272 RMC6272 inhibitor inhibit